$ARGS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ARGOS THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ARGOS THERAPEUTICS INC. Get notifications about new insider transactions in ARGOS THERAPEUTICS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 19 2015 | ARGS | ARGOS THERAPEUTICS ... | Nicolette Charles A. | CSO | Option Exercise | A | 7.80 | 75,000 | 585,000 | 75,000 | |
Jun 19 2015 | ARGS | ARGOS THERAPEUTICS ... | MIESOWICZ FREDERICK | COO | Option Exercise | A | 7.80 | 20,000 | 156,000 | 20,000 | |
Jun 19 2015 | ARGS | ARGOS THERAPEUTICS ... | Abbey Jeffrey D | Chief Executive Off ... | Option Exercise | A | 7.80 | 120,000 | 936,000 | 120,000 | |
Jun 19 2015 | ARGS | ARGOS THERAPEUTICS ... | Harrelson Lori R. | Vice President of F ... | Option Exercise | A | 7.80 | 20,000 | 156,000 | 20,000 | |
Jun 19 2015 | ARGS | ARGOS THERAPEUTICS ... | Plessinger Douglas C. | See Remarks | Option Exercise | A | 7.80 | 30,000 | 234,000 | 30,000 | |
Jun 19 2015 | ARGS | ARGOS THERAPEUTICS ... | van Deventer Sander | Director | Option Exercise | A | 7.80 | 5,500 | 42,900 | 5,500 | |
Jun 19 2015 | ARGS | ARGOS THERAPEUTICS ... | Birner Hubert | Director | Option Exercise | A | 7.80 | 5,500 | 42,900 | 5,500 | |
Jun 19 2015 | ARGS | ARGOS THERAPEUTICS ... | Vinogradov Alexey Alexandrovic ... | Director | Option Exercise | A | 7.80 | 5,500 | 42,900 | 5,500 | |
Jun 19 2015 | ARGS | ARGOS THERAPEUTICS ... | Petrov Andrei Vladimirovich | Director | Option Exercise | A | 7.80 | 5,500 | 42,900 | 5,500 | |
Jun 19 2015 | ARGS | ARGOS THERAPEUTICS ... | Lamarre Jean | Director | Option Exercise | A | 7.80 | 5,500 | 42,900 | 5,500 | |
Jun 18 2015 | ARGS | ARGOS THERAPEUTICS ... | Underdown Brian J. | Director | Option Exercise | A | 7.80 | 5,500 | 42,900 | 16,500 | |
Jul 30 2014 | ARGS | ARGOS THERAPEUTICS ... | Nicolette Charles A. | CSO | Option Exercise | A | 6.09 | 18,000 | 109,620 | 297,803 | |
Jul 30 2014 | ARGS | ARGOS THERAPEUTICS ... | Abbey Jeffrey D | Chief Executive Off ... | Option Exercise | A | 6.09 | 58,400 | 355,656 | 687,960 | |
Jul 30 2014 | ARGS | ARGOS THERAPEUTICS ... | Harrelson Lori R. | Vice President of F ... | Option Exercise | A | 6.09 | 10,200 | 62,118 | 128,239 | |
Jul 30 2014 | ARGS | ARGOS THERAPEUTICS ... | Plessinger Douglas C. | See Remarks | Option Exercise | A | 6.09 | 10,200 | 62,118 | 185,076 | |
Jul 30 2014 | ARGS | ARGOS THERAPEUTICS ... | MIESOWICZ FREDERICK | COO | Option Exercise | A | 6.09 | 10,200 | 62,118 | 185,075 | |
Mar 24 2014 | ARGS | ARGOS THERAPEUTICS ... | Vinogradov Alexey Alexandrovic ... | Director | Option Exercise | A | 11.09 | 11,000 | 121,990 | 11,000 | |
Mar 24 2014 | ARGS | ARGOS THERAPEUTICS ... | van Deventer Sander | Director | Option Exercise | A | 11.09 | 11,000 | 121,990 | 11,000 | |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Abbey Jeffrey D | Chief Executive Off ... | Option Exercise | C | 0.00 | 1,267 | 0 | 0 | |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Abbey Jeffrey D | Chief Executive Off ... | Option Exercise | C | 0.00 | 1,238 | 0 | 0 | |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Abbey Jeffrey D | Chief Executive Off ... | Option Exercise | C | 0.00 | 75 | 0 | 0 | |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Abbey Jeffrey D | Chief Executive Off ... | Buy | C | 0.00 | 1,267 | 0 | 2,580 | 1.3 K to 2.6 K (+96.50 %) |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Abbey Jeffrey D | Chief Executive Off ... | Buy | C | 0.00 | 1,238 | 0 | 1,313 | 75 to 1.3 K (+1,650.67 %) |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Abbey Jeffrey D | Chief Executive Off ... | Buy | C | 0.00 | 75 | 0 | 75 | 0 to 75 |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | MIESOWICZ FREDERICK | COO | Option Exercise | C | 0.00 | 4,941 | 0 | 0 | |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | MIESOWICZ FREDERICK | COO | Option Exercise | C | 0.00 | 619 | 0 | 0 | |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | MIESOWICZ FREDERICK | COO | Option Exercise | C | 0.00 | 37 | 0 | 0 | |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | MIESOWICZ FREDERICK | COO | Buy | C | 0.00 | 4,941 | 0 | 5,597 | 656 to 5.6 K (+753.20 %) |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | MIESOWICZ FREDERICK | COO | Buy | C | 0.00 | 619 | 0 | 656 | 37 to 656 (+1,672.97 %) |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | MIESOWICZ FREDERICK | COO | Buy | C | 0.00 | 37 | 0 | 37 | 0 to 37 |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Nicolette Charles A. | CSO | Option Exercise | C | 0.00 | 1,859 | 0 | 0 | |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Nicolette Charles A. | CSO | Option Exercise | C | 0.00 | 4,941 | 0 | 0 | |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Nicolette Charles A. | CSO | Buy | C | 0.00 | 1,859 | 0 | 6,800 | 4.9 K to 6.8 K (+37.62 %) |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Nicolette Charles A. | CSO | Buy | C | 0.00 | 4,941 | 0 | 4,941 | 0 to 4.9 K |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Underdown Brian J. | Director | Option Exercise | C | 0.00 | 569,990 | 0 | 0 | |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Underdown Brian J. | Director | Option Exercise | C | 0.00 | 582,769 | 0 | 0 | |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Underdown Brian J. | Director | Option Exercise | C | 0.00 | 43,185 | 0 | 0 | |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Underdown Brian J. | Director | Option Exercise | C | 0.00 | 13,131 | 0 | 0 | |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Underdown Brian J. | Director | Buy | P | 8.00 | 40,497 | 323,976 | 1,249,572 | 1.2 M to 1.2 M (+3.35 %) |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Underdown Brian J. | Director | Buy | C | 0.00 | 569,990 | 0 | 1,209,075 | 639.1 K to 1.2 M (+89.19 %) |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Underdown Brian J. | Director | Buy | C | 0.00 | 582,769 | 0 | 639,085 | 56.3 K to 639.1 K (+1,034.82 %) |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Underdown Brian J. | Director | Buy | C | 0.00 | 43,185 | 0 | 56,316 | 13.1 K to 56.3 K (+328.88 %) |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Underdown Brian J. | Director | Buy | C | 0.00 | 13,131 | 0 | 13,131 | 0 to 13.1 K |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Cooperatieve AAC LS U.A. | 10% Owner | Option Exercise | C | 0.00 | 1,428,888 | 0 | 0 | |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Cooperatieve AAC LS U.A. | 10% Owner | Option Exercise | C | 0.00 | 984,840 | 0 | 0 | |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Cooperatieve AAC LS U.A. | 10% Owner | Buy | P | 8.00 | 36,416 | 291,328 | 2,450,144 | 2.4 M to 2.5 M (+1.51 %) |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Cooperatieve AAC LS U.A. | 10% Owner | Buy | C | 0.00 | 1,428,888 | 0 | 2,413,728 | 984.8 K to 2.4 M (+145.09 %) |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Cooperatieve AAC LS U.A. | 10% Owner | Buy | C | 0.00 | 984,840 | 0 | 984,840 | 0 to 984.8 K |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Birner Hubert | Director | Option Exercise | C | 0.00 | 663,082 | 0 | 0 | |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Birner Hubert | Director | Option Exercise | C | 0.00 | 665,583 | 0 | 0 | |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Birner Hubert | Director | Option Exercise | C | 0.00 | 94,351 | 0 | 0 | |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Birner Hubert | Director | Option Exercise | C | 0.00 | 8,202 | 0 | 0 | |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Birner Hubert | Director | Buy | P | 8.00 | 39,873 | 318,984 | 1,471,091 | 1.4 M to 1.5 M (+2.79 %) |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Birner Hubert | Director | Buy | C | 0.00 | 663,082 | 0 | 1,431,218 | 768.1 K to 1.4 M (+86.32 %) |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Birner Hubert | Director | Buy | C | 0.00 | 665,583 | 0 | 768,136 | 102.6 K to 768.1 K (+649.01 %) |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Birner Hubert | Director | Buy | C | 0.00 | 94,351 | 0 | 102,553 | 8.2 K to 102.6 K (+1,150.34 %) |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Birner Hubert | Director | Buy | C | 0.00 | 8,202 | 0 | 8,202 | 0 to 8.2 K |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | van Deventer Sander | Director | Option Exercise | C | 0.00 | 1,428,888 | 0 | 0 | |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | van Deventer Sander | Director | Option Exercise | C | 0.00 | 984,840 | 0 | 0 | |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | van Deventer Sander | Director | Buy | P | 8.00 | 36,416 | 291,328 | 2,450,144 | 2.4 M to 2.5 M (+1.51 %) |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | van Deventer Sander | Director | Buy | C | 0.00 | 1,428,888 | 0 | 2,413,728 | 984.8 K to 2.4 M (+145.09 %) |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | van Deventer Sander | Director | Buy | C | 0.00 | 984,840 | 0 | 984,840 | 0 to 984.8 K |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Pharmstandard International S. ... | 10% Owner | Option Exercise | C | 0.00 | 4,708,549 | 0 | 0 | |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Pharmstandard International S. ... | 10% Owner | Buy | P | 8.00 | 1,275,000 | 10,200,000 | 5,983,549 | 4.7 M to 6 M (+27.08 %) |
Feb 12 2014 | ARGS | ARGOS THERAPEUTICS ... | Pharmstandard International S. ... | 10% Owner | Buy | C | 0.00 | 4,708,549 | 0 | 4,708,549 | 0 to 4.7 M |
Aug 18 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.62 | 4,086 | 22,963 | 4,541,100 | 4.5 M to 4.5 M (-0.09 %) |
Aug 18 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.61 | 2,800 | 15,708 | 4,545,186 | 4.5 M to 4.5 M (-0.06 %) |
Aug 18 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.60 | 9,114 | 51,038 | 4,547,986 | 4.6 M to 4.5 M (-0.20 %) |
Aug 18 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.59 | 8,000 | 44,720 | 4,557,100 | 4.6 M to 4.6 M (-0.18 %) |
Aug 18 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.58 | 5,514 | 30,768 | 4,565,100 | 4.6 M to 4.6 M (-0.12 %) |
Aug 18 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.57 | 6,939 | 38,650 | 4,570,614 | 4.6 M to 4.6 M (-0.15 %) |
Aug 18 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.56 | 12,723 | 70,740 | 4,577,553 | 4.6 M to 4.6 M (-0.28 %) |
Aug 18 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.55 | 10,600 | 58,830 | 4,590,276 | 4.6 M to 4.6 M (-0.23 %) |
Aug 18 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.53 | 1,200 | 6,636 | 4,600,876 | 4.6 M to 4.6 M (-0.03 %) |
Aug 18 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.52 | 4,500 | 24,840 | 4,602,076 | 4.6 M to 4.6 M (-0.10 %) |
Aug 18 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.51 | 24 | 132 | 4,606,576 | 4.6 M to 4.6 M (0.00 %) |
Aug 17 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.70 | 2,400 | 13,680 | 4,606,600 | 4.6 M to 4.6 M (-0.05 %) |
Aug 17 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.63 | 400 | 2,252 | 4,609,000 | 4.6 M to 4.6 M (-0.01 %) |
Aug 17 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.62 | 2,930 | 16,467 | 4,609,400 | 4.6 M to 4.6 M (-0.06 %) |
Aug 17 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.61 | 2,670 | 14,979 | 4,612,330 | 4.6 M to 4.6 M (-0.06 %) |
Aug 17 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.60 | 4,300 | 24,080 | 4,615,000 | 4.6 M to 4.6 M (-0.09 %) |
Aug 17 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.57 | 400 | 2,228 | 4,619,300 | 4.6 M to 4.6 M (-0.01 %) |
Aug 17 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.56 | 400 | 2,224 | 4,619,700 | 4.6 M to 4.6 M (-0.01 %) |
Aug 17 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.55 | 4,700 | 26,085 | 4,620,100 | 4.6 M to 4.6 M (-0.10 %) |
Aug 17 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.54 | 1,300 | 7,202 | 4,624,800 | 4.6 M to 4.6 M (-0.03 %) |
Aug 17 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.51 | 900 | 4,959 | 4,626,100 | 4.6 M to 4.6 M (-0.02 %) |
Aug 17 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.50 | 2,000 | 11,000 | 4,627,000 | 4.6 M to 4.6 M (-0.04 %) |
Aug 17 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.49 | 6,261 | 34,373 | 4,629,000 | 4.6 M to 4.6 M (-0.14 %) |
Aug 17 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.48 | 8,044 | 44,081 | 4,635,261 | 4.6 M to 4.6 M (-0.17 %) |
Aug 17 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.47 | 1,595 | 8,725 | 4,643,305 | 4.6 M to 4.6 M (-0.03 %) |
Aug 17 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.46 | 1,500 | 8,190 | 4,644,900 | 4.6 M to 4.6 M (-0.03 %) |
Aug 17 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.44 | 2,300 | 12,512 | 4,646,400 | 4.6 M to 4.6 M (-0.05 %) |
Aug 17 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.43 | 4,300 | 23,349 | 4,648,700 | 4.7 M to 4.6 M (-0.09 %) |
Aug 17 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.42 | 600 | 3,252 | 4,653,000 | 4.7 M to 4.7 M (-0.01 %) |
Aug 16 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 6.20 | 3,000 | 18,600 | 4,653,600 | 4.7 M to 4.7 M (-0.06 %) |
Aug 16 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 6.19 | 500 | 3,095 | 4,656,600 | 4.7 M to 4.7 M (-0.01 %) |
Aug 16 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 6.17 | 2,193 | 13,531 | 4,657,100 | 4.7 M to 4.7 M (-0.05 %) |
Aug 16 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 6.16 | 3,693 | 22,749 | 4,659,293 | 4.7 M to 4.7 M (-0.08 %) |
Aug 16 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 6.15 | 4,412 | 27,134 | 4,662,986 | 4.7 M to 4.7 M (-0.09 %) |
Aug 16 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 6.14 | 4,795 | 29,441 | 4,667,398 | 4.7 M to 4.7 M (-0.10 %) |
Aug 16 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 6.12 | 7,312 | 44,749 | 4,672,193 | 4.7 M to 4.7 M (-0.16 %) |
Aug 16 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 6.11 | 95 | 580 | 4,679,505 | 4.7 M to 4.7 M (0.00 %) |
Aug 16 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 6.10 | 1,000 | 6,100 | 4,679,600 | 4.7 M to 4.7 M (-0.02 %) |
Aug 16 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 6.08 | 6,919 | 42,068 | 4,680,600 | 4.7 M to 4.7 M (-0.15 %) |
Aug 16 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 6.05 | 3,000 | 18,150 | 4,687,519 | 4.7 M to 4.7 M (-0.06 %) |
Aug 16 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.97 | 3,998 | 23,868 | 4,690,519 | 4.7 M to 4.7 M (-0.09 %) |
Aug 16 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.96 | 2,600 | 15,496 | 4,694,517 | 4.7 M to 4.7 M (-0.06 %) |
Aug 16 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.95 | 1,700 | 10,115 | 4,697,117 | 4.7 M to 4.7 M (-0.04 %) |
Aug 16 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.94 | 3,602 | 21,396 | 4,698,817 | 4.7 M to 4.7 M (-0.08 %) |
Aug 16 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.93 | 1,200 | 7,116 | 4,702,419 | 4.7 M to 4.7 M (-0.03 %) |
Aug 16 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.92 | 3,081 | 18,240 | 4,703,619 | 4.7 M to 4.7 M (-0.07 %) |
Aug 16 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.91 | 2,050 | 12,116 | 4,706,700 | 4.7 M to 4.7 M (-0.04 %) |
Aug 16 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.90 | 100,950 | 595,605 | 4,708,750 | 4.8 M to 4.7 M (-2.10 %) |
Aug 16 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.89 | 600 | 3,534 | 4,809,700 | 4.8 M to 4.8 M (-0.01 %) |
Aug 16 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.87 | 2,600 | 15,262 | 4,810,300 | 4.8 M to 4.8 M (-0.05 %) |
Aug 16 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.85 | 500 | 2,925 | 4,812,900 | 4.8 M to 4.8 M (-0.01 %) |
Aug 16 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.83 | 2,500 | 14,575 | 4,813,400 | 4.8 M to 4.8 M (-0.05 %) |
Aug 16 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.82 | 1,700 | 9,894 | 4,815,900 | 4.8 M to 4.8 M (-0.04 %) |
Aug 16 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.80 | 300 | 1,740 | 4,817,600 | 4.8 M to 4.8 M (-0.01 %) |
Aug 16 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.78 | 600 | 3,468 | 4,817,900 | 4.8 M to 4.8 M (-0.01 %) |
Aug 16 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.75 | 3,000 | 17,250 | 4,818,500 | 4.8 M to 4.8 M (-0.06 %) |
Aug 13 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.57 | 2,000 | 11,140 | 4,821,500 | 4.8 M to 4.8 M (-0.04 %) |
Aug 13 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.56 | 3,206 | 17,825 | 4,823,500 | 4.8 M to 4.8 M (-0.07 %) |
Aug 13 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.55 | 54 | 300 | 4,826,706 | 4.8 M to 4.8 M (0.00 %) |
Aug 13 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.54 | 5,500 | 30,470 | 4,826,760 | 4.8 M to 4.8 M (-0.11 %) |
Aug 13 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.51 | 2,000 | 11,020 | 4,832,260 | 4.8 M to 4.8 M (-0.04 %) |
Aug 13 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.50 | 1,342 | 7,381 | 4,834,260 | 4.8 M to 4.8 M (-0.03 %) |
Aug 13 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.49 | 600 | 3,294 | 4,835,602 | 4.8 M to 4.8 M (-0.01 %) |
Aug 13 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.48 | 1,340 | 7,343 | 4,836,202 | 4.8 M to 4.8 M (-0.03 %) |
Aug 13 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.47 | 1,258 | 6,881 | 4,837,542 | 4.8 M to 4.8 M (-0.03 %) |
Aug 13 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.46 | 1,500 | 8,190 | 4,838,800 | 4.8 M to 4.8 M (-0.03 %) |
Aug 13 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.45 | 700 | 3,815 | 4,840,300 | 4.8 M to 4.8 M (-0.01 %) |
Aug 13 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.44 | 5,186 | 28,212 | 4,841,000 | 4.8 M to 4.8 M (-0.11 %) |
Aug 13 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.43 | 4,200 | 22,806 | 4,846,186 | 4.9 M to 4.8 M (-0.09 %) |
Aug 13 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.42 | 2,564 | 13,897 | 4,850,386 | 4.9 M to 4.9 M (-0.05 %) |
Aug 13 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.40 | 2,950 | 15,930 | 4,852,950 | 4.9 M to 4.9 M (-0.06 %) |
Aug 13 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.38 | 1,800 | 9,684 | 4,855,900 | 4.9 M to 4.9 M (-0.04 %) |
Aug 13 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.37 | 2,900 | 15,573 | 4,857,700 | 4.9 M to 4.9 M (-0.06 %) |
Aug 13 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.35 | 2,300 | 12,305 | 4,860,600 | 4.9 M to 4.9 M (-0.05 %) |
Aug 13 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.31 | 600 | 3,186 | 4,862,900 | 4.9 M to 4.9 M (-0.01 %) |
Aug 11 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.27 | 1,805 | 9,512 | 4,863,500 | 4.9 M to 4.9 M (-0.04 %) |
Aug 11 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.26 | 1,600 | 8,416 | 4,865,305 | 4.9 M to 4.9 M (-0.03 %) |
Aug 11 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.25 | 32,845 | 172,436 | 4,866,905 | 4.9 M to 4.9 M (-0.67 %) |
Aug 11 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.24 | 2,400 | 12,576 | 4,899,750 | 4.9 M to 4.9 M (-0.05 %) |
Aug 11 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.23 | 10,200 | 53,346 | 4,902,150 | 4.9 M to 4.9 M (-0.21 %) |
Aug 11 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.22 | 1,000 | 5,220 | 4,912,350 | 4.9 M to 4.9 M (-0.02 %) |
Aug 11 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.21 | 1,600 | 8,336 | 4,913,350 | 4.9 M to 4.9 M (-0.03 %) |
Aug 11 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.20 | 550 | 2,860 | 4,914,950 | 4.9 M to 4.9 M (-0.01 %) |
Aug 11 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.45 | 4,800 | 26,160 | 4,915,500 | 4.9 M to 4.9 M (-0.10 %) |
Aug 11 2004 | ARGS | ARGOS THERAPEUTICS ... | MERIX BIOSCIENCE INC | 10% Owner | Sell | S | 5.42 | 800 | 4,336 | 4,920,300 | 4.9 M to 4.9 M (-0.02 %) |